New MS Drug Trial Will Rely on Remote Patient Telemonitoring

Published Online: Thursday, February 14, 2013
Follow Pharmacy_Times:
The FDA awarded biopharmaceutical company Transparency Life Sciences (TLS) Investigational New Drug status for their innovative clinical trial design. The design of this Phase 2a remote monitoring trial—the first of its kind—will rely heavily on data collected from participants’ homes and will include vital sign monitoring and secure video interaction between subjects and researchers through the telemonitoring company AMC Health.

Researchers plan to enroll 180 MS subjects into this telehealth initiative and evaluate the safety and efficacy of blood pressure drug lisinopril in the treatment of MS. The investigators are hopeful that this new type of trial design will effectively eliminate the kind of researcher bias that can occur with the collection of data in the clinical setting. In addition, AMC Health estimates that by using remote technologies and crowd sourcing, TLS can conduct the trial for $3.5 million less than the cost of a traditional Phase 2a trial.

“FDA approval of this innovative study design is a significant milestone,” noted John Holland, senior vice president for research and business development at AMC Health. He said mobile video interactions over the 12-month study period will “increase quality and quantity of data, and reduce the burden on patients.”

Related Articles
Despite an unprecedented boom in using technology to provide health care, telemedicine remains the red-headed stepchild of the industry.
Walgreens today introduced a new telehealth offering that will give Walgreens website users 24/7 access to U.S. board-certified doctors through its mobile application. With today’s launch, the service is now available to users in California and Michigan, with plans to rollout to additional states and markets over time.
Coaching patients with chronic obstructive pulmonary disease on relaxation techniques can improve their quality of life and even ease their symptoms.
Pharmacy Times, the American Journal of Managed Care, and the Convenient Care Association presented a panel discussion on how the Affordable Care Act is affecting the health care landscape and opportunities it is offering to retail clinics.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$